Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luís Piñana, Anna Sureda, Rodrigo Martino et al.|Experimental Hematology and Oncology|2020Cited by 159
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luís Piñana, David Navarro, Ángel Cedillo et al.|Journal of Hematology & Oncology|2022Cited by 39
Few and Nonsevere Adverse Infusion Events Using an Automated Method for Diluting and Washing before Unrelated Single Cord Blood TransplantationNerea Castillo, Sergio Querol, Izaskun Elorza et al.|Transplantation and Cellular Therapy|2014Cited by 7
Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Experience in a Multi-Centre StudyVirginia Escamilla Gómez, Josè Antonio Pérez-Simón, Valentín García‐Gutiérrez et al.|Blood|2022Cited by 2